The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

Tue, 15th Sep 2020 22:08

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Mortgage Advice Bureau Holdings PLC - Derby-based mortgage adviser - Launches Mortgage Advice Bureau Later Life, its exclusive strategic alliance with later life lending business Key Group. MAB Later Life consists of a panel of four lenders including Key's more2Life lifetime mortgage lenders. First phase of alliance involved distributing later life mortgage products through a small pilot group of existing MAB advisers, which is now being extended to firms outside the group.

----------

Botswana Diamonds PLC - Irish exploration and project development company - Posts preliminary results from next phase of Marsfontein project drilling campaign, testing historical anomaly identified as M17 to examine potential as enlargement on the M8 kimberlite dyke. Hole ID M17H001 intersects 4 metres of kimberlite from 54 to 58 metres, among the thickest kimberlite intersections at the Marsfontein - Thorny River project area so far. This warrants detailed ground geophysics. No kimberlite identified in hole ID M17H002.

----------

Gabelli Value Plus+ Trust PLC - US equities investor - Largest shareholder ACG will not support liquidation proposals. As it holds more than 25% of voting rights and the proposals would need at least 75% approval, the board will not put forward its liquidation proposals at this time. Evaluates options available. Firm had planned to put forward proposals for members' voluntary liquidation after a 66% majority of votes at its July AGM were opposed to its continuation resolution.

----------

Manolete Partners PLC - UK-focused insolvency litigation financing firm - Completes one of the larger cases in its portfolio of UK insolvency claims, which settles for gross amount of GBP15.0 million. In current trade period since March 31, has completed 40 cases, including the larger claim which will itself generate a GBP4.1 million realised gain and make an approximately GBP2.1 million contribution to net pretax profit for the current accounting period. No material write-offs sustained in Manolete case portfolio. New business develops well in five months to August, 84 new cases either acquired or funded, up 65% year-on-year.

----------

OptiBiotix Health PLC - York-based life sciences company - Enters agreement with undisclosed US company aiming to achieve large scale manufacture and commercialisation of certain SweetBiotix products. Deal grants US company exclusive worldwide licence in return for it bearing product manufacturing, marketing, and all future commercialisation costs for various SweetBiotix products. "Modes six-figure payment" to be made to OptiBiotix in singing agreement an as 12 monthly intervals until product launch. Similar payment plus royalties on on all future sales of SweetBiotix to 11 partners once US company starts selling SweetBiotix products.

----------

McKay Securities PLC - real estate investment trust focused on office, industrial and logistics markets in south east and London - Lets whole of 135 Theale Logistics Park at Junction 12 of M4 near Reading to logistics operator. New tenant agrees to 10-year FRI lease term at rend 2.0% ahead of March ERV. Letting takes McKay's contracted rental income as at March 31 up 5.3% to GBP29.8 million.

----------

President Energy PLC - oil and gas company focusing on Latin America - Concludes operations testing of EVx-1 at Rio Negro operations in Argentina. Flow rates, pressure build up support initial testing results with USD250,000 workover of old well having "proved to be excellent value". Production rates range between 25,000 to 150,000 cubic metres per day of gas with small amount of condensate. Well to be put on stream initially producing 80,000 cubic metres per day of gas. "The data obtained from the testing is now being analysed to determine the producible volume of the reservoir and its characteristics." Old PFO-33 turned into water disposal well, replacing prior well PFO-17 which ceased to be operable around 3 months ago. President: "The drilling rig is now expected to start mobilising during the course of this week for drilling operations to commence on schedule before the end of September."

----------

Tex Holdings PLC - Suffolk-based engineering and plastics manufacturing group - Applies to Financial Conduct Authority to cancel its main market shares, with the effective date of cancellation to be on or near October 13. Listing suspended April 2019 over failure to supply audited accounts for 2018 on time. Explains that: "Continued listing of the shares incurs significant cost while presenting an obstacle to potential sources of funding."

----------

Eden Research PLC - biopesticides and plastic-free formulation technology company - Obtains patent in Australia for its Sustaine encapsulation technology. Patent is for the use of Sustaine biodegradable micro-spheres produced from yeast extract - and is the first patent anywhere in the world specifically covering the use of Sustaine with third party active ingredients.

----------

Emmerson PLC - Morocco-focused potash development company - Says "multiple workstreams in progress" for further de-risking of its Khemisset potash project. Permitting process on track with main permits set to be in place in the first half of 2021. Investigating operations for staged development so cut upfront capital costs and provides financing flexibility. Talks with possible strategic partners, anchor investors, debt providers, going well.

----------

Evgen Pharma PLC - Liverpool-headquartered clinical-stage drug development company - Licences its sulforaphane stabilisation technology for use in various non-pharmaceutical applications to Juvenescence Ltd. Juvenescence plans to market and sell a high-end nutritional health product containing sulforaphane extracted from natural sources. Evgen to receive milestone and option payments totalling maximum USD10.5 million plus royalties on future product sales. Initial payment of USD250,000 on signing of agreement.

----------

Amryt Pharma PLC - pharmaceutical company - Notes positive opinion on orphan designation for drug AP103 in Epidermolysis Bullosa from European Medicines Agency's Committee for Orphan Medicinal Products. Orphan drug destination in EU granted within 30 days of positive COMP opinion. Amryt notes: "This designation provides certain regulatory and financial incentives including but not limited to product market exclusivity for ten years in the EU following regulatory approval." Epidermolysis Bullosa is a genetic skin disorder causing skin layers and internal body lining to separate and currently has no approved treatments.

----------

HML Holdings PLC - Surrey-based property management services firm - AIM delisting expected to occur October 13 without requirement for shareholder resolution approval. This follows acceptance of offer by BDO Nominee Co Ltd to acquire company for GBP19.0 million in total. BDO will purchase shares for 37.5 pence each. BDO Nominee is a company formed under direction of Harwood Capital LLP for the purpose of making the offer.

----------

Chesterfield Resources PLC - copper-gold exploration and development company active in Cyprus - Begins diamond drill programme at Troodos West copper-gold exploration licences in Cyprus. Intending to drill a 2,000 metre programme consisting of holes of around 150 metres each, with programme set to last until around October end. Will simultaneously carry out an AMT geophysics survey plus percussion drilling in integrated exploration programme. Goal is to discover and test volcanognic massive sulphide deposits buried at shallow depth in an area of historic mines.

----------

Symphony Environmental Technologies PLC - Borehamwood-based developer of additives to make ordinary plastic biodegradable - Receives notice from Vincel Investment Holdings Ltd to exercise warrants representing 5.0 million share. Warrants granted July 19. Symphony to receive GBP1.0 million in cash proceeds.

----------

TP Group PLC - Reading-based consulting, software and engineering services provider - Receives new orders totalling around GBP4.0 million from UK Ministry of Defence to supply oxygen generation and carbon dioxide removal devices. Orders are part of GBP22 million framework agreement previously announced in April 2017. Devised to be supplied to Royal Navy in fourth quarter of 2020 and into 2021.

----------

Distil PLC - London-based owner of premium drinks brand Diva Vodka plus others - Launches RedLeg Banana Rum, second flavour extension for its Redleg Rum brand. Conducts branding refresh across range.

----------

Haydale Graphene Industries PLC - Ammanford, Wales-based nanomaterial producer - Inks contracts to provides services for the collaborative development of graphene and nano material-enhanced products for use in Dowty Propellers products. Haydale and Dowty to collaborate on developing erosion-resistant coating with addition of Haydale's Silicone Carbide Microfibers as well as other products.

----------

Boku Inc - US-based mobile payments solution provider - Recently acquires subsidiary Fortumo working with Amazon.com Inc to allow launch of Amazon Prime bundle service for Jio Platforms subscribers. Jio is a digital services company in India and is offering 1 year of Amazon Prime with select broadband plans.

----------

Galileo Resources PLC -miner with projects in Botswana, Zambia and South Africa - Announces conditional acquisition of Africibum Co Pty Ltd and its interests in Botswana's North East Kalahari Copper Belt project. Consideration is 42.0 million Galileo shares priced at 0.779 pence each.

----------

Merian Chrysalis Investment Co Ltd - London-based investor in later stage private companies - Confirms that asset referred to in Friday announcement of approximately GBP23 million follow-on investment was Klarna Holding AB. Klarna has conducted a USD650 million primary funding round with an additional secondary sell-down by some investors, with round valuing Klarna at USD10.65 billion, up from USD5.5 billion in August 2019. Merian Chrysalis gross cash position now approximately GBP31 million with Klarna stake worth around GBP96 million.

----------

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 Aug 2023 10:09

AIM WINNERS & LOSERS: Deltex plummets on return to AIM; Blancco rises

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
13 Jul 2023 15:58

UK shareholder meetings calendar - next 7 days

Friday 14 July 
Templeton Emerging Markets Investment Trust PLCAGM
Monday 17 July 
All ThingsConsidered Group PLCAGM
Tower Resources PLCAGM
Tuesday 18 July 
Alkemy Capital Investments PLCAGM
Bloomsbury Publishing PLCAGM
CT Property Trust LtdGM re takeover by LondonMetric Property
e-Therapeutics PLCAGM
MobilityOne LtdEGM re Tete planned JV deadline extension
SmartSpace Software PLCAGM
Strategic Minerals PLCAGM
Wynnstay Properties PLCAGM
Wednesday 19 July 
Berkeley Energia LtdAGM
Caledonian Trust PLCAGM
DG Innovate PLCAGM
Experian PLCAGM
HICL Infrastructure PLCAGM
Mind Gym PLCAGM
Sportech PLCGM re share capital restructure
Triple Point Income VCT PLCAGM
Thursday 20 July 
ACG Acquisition Co LtdEGM re acquisition of the Atlantic Nickel
Big Yellow Group PLCAGM
CT UK High Income Trust PLCAGM
Evgen Pharma PLCAGM
FD Technologies PLCAGM
Fuller, Smith & Turner PLCAGM
GB Group PLCAGM
Halma PLCAGM
Intermediate Capital Group PLCAGM
International Distributions Services PLCAGM
Fidelity China Special Situations PLCAGM
Johnson Matthey PLCAGM
Kingspan Group PLCEGM re delisting
Pennon Group PLCAGM
Premier Foods PLCAGM
Premier Miton Group PLCAGM
Qinetiq Group PLCAGM
SSE PLCAGM
TR Property Investment Trust PLCAGM
VP PLCAGM
Weiss Korea Opportunity Fund LtdAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Jun 2023 10:17

AIM WINNERS & LOSERS: Unbound shares drop as calls off sales process

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
27 Jun 2023 10:01

Evgen Pharma's SFX-01 has positive effects for treating a rare cancer

(Alliance News) - Evgen Pharma PLC on Tuesday said its lead asset SFX-01 has radio-sensitising effects in vivo in a form of soft tissue sarcoma, as part of its research partnership with Sapienza University of Rome.

Read more
19 Jun 2023 10:05

Evgen collaborator receives grant from KWF Dutch Cancer Society

(Alliance News) - Evgen Pharma PLC on Monday said its collaborator at the Erasmus University Medical Center in Rotterdam has received notice of a grant from KWF Dutch Cancer Society.

Read more
7 Jun 2023 11:41

Evgen Pharma confident amid Stalicla deal; CFO Moulson to retire

(Alliance News) - Evgen Pharma PLC on Wednesday reported a widened annual loss and said its Chief Financial Officer Richard Moulson will retire in late July.

Read more
31 May 2023 15:46

UK earnings, trading statements calendar - next 7 days

Thursday 1 June 
Auto Trader Group PLCFull Year Results
Dr Martens PLCFull Year Results
Pennon Group PLCFull Year Results
Trinity Exploration & Production PLCFull Year Results
Friday 2 June 
TR Property Investment Trust PLCFull Year Results
Nostrum Oil & Gas PLCFull Year Results
Monday 5 June 
Celadon Pharmaceuticals PLCFull Year Results
Hercules Site Services PLCHalf Year Results
Itaconix PLCFull Year Results
Sirius Real Estate LtdFull Year Results
ValiRx PLCFull Year Results
Verici Dx PLCFull Year Results
Tuesday 6 June 
British American Tobacco PLCTrading Statement
Chemring Group PLCHalf Year Results
Ferguson PLCQ3 Results
Gooch & Housego PLCHalf Year Results
Jadestone Energy PLCFull Year Results
N Brown Group PLCFull Year Results
NewRiver REIT PLCFull Year Results
Oxford Metrics PLCHalf Year Results
Paragon Banking Group PLCHalf Year Results
Speedy Hire PLCFull Year Results
Warehouse REIT PLCFull Year Results
Wednesday 7 June 
discoverIE Group PLCFull Year Results
Evgen Pharma PLCFull Year Results
LXi REIT PLCFull Year Results
Ramsdens Holdings PLCHalf Year Results
Residential Secure Income PLCHalf Year Results
Vp PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
22 Mar 2023 11:10

IN BRIEF: Evgen Pharma shares up as pharmacokinetic data announced

Evgen Pharma PLC - Cheshire, England-based clinical stage drug development company focusing on sulforaphane-based medicines - Presents top line pharmacokinetic data for its placebo-controlled, dose-escalating, randomised Phase I/Ib clinical trial. Says the study is aimed to provide further insight into the pharmacokinetic and pharmacodynamic characteristics of the new enteric coated tablet formulation of the company's lead asset SFX-01, as well as investigating how sulforaphane released from the tablet engages with targets of interest. Says SFX-01 shows no serious adverse effects and the study is on schedule for full reporting in the second quarter.

Read more
22 Mar 2023 10:30

AIM WINNERS & LOSERS: Pathfinder finds way forward in Mozambique

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
16 Mar 2023 16:35

Evgen notes evidence of radiosensitisation by SFX-01 in cancer cells

(Alliance News) - Evgen Pharma PLC said on Thursday it had found further evidence of radiosensitisation by SFX-01 in sarcoma cells.

Read more
13 Mar 2023 12:18

SUMMARY: London listings with exposure to Silicon Valley Bank

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
25 Jan 2023 10:40

Evgen Pharma completes dosing of clinical trial for SFX-01 tablet

(Alliance News) - Evgen Pharma PLC on Wednesday said it completed the dosing of all three cohorts of the phase 1/1b clinical trial of its SFX-01 tablet formulation.

Read more
8 Dec 2022 13:57

Evgen Pharma loss, operating expenses widen; SFX-01 study on schedule

(Alliance News) - Evgen Pharma PLC on Thursday said interim loss widened, but noted the healthy volunteer study of its SFX-01 formulation remains on schedule.

Read more
16 Nov 2022 16:11

Evgen Pharma starts clinical trial of new SFX-01 tablet

(Alliance News) - Evgen Pharma PLC said on Wednesday it had started a randomised, placebo-controlled clinical trial of its new SFX-01 tablet.

Read more
16 Nov 2022 14:05

Evgen Pharma doses first volunteers in SFX-01 trial

(Sharecast News) - Clinical-stage drug developer Evgen Pharma has dosed the first group of healthy volunteers in its placebo-controlled, dose-escalating, randomised phase 1 and 1b clinical trial, it announced on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.